NEW YORK (GenomeWeb) – Pressure Biosciences today reported its revenues from products and services increased 14 percent year over year for the third quarter ended Sept. 30, as its overall revenues slipped 11 percent.

Total revenues, generated wholly from the sale of products and services, were $372,545, down 11 percent from $420,762 in Q3 2013. Products and services revenue in Q3 2013 was $327,958. Consumables sales were $52,000, nearly flat with $51,000 for Q3 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.